Skip to content

Clinical study of ciprofol injection in patients with painless induced abortion

A randomized controlled clinical study on the efficacy and safety of ciprofol injection in patients with painless induced abortion

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100054917
Enrollment
Unknown
Registered
2021-12-29
Start date
2022-01-01
Completion date
Unknown
Last updated
2022-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Painless induced abortion

Interventions

Propofol group:Intravenous injection of Propofol 1.6mg/kg

Sponsors

The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-45 years; 2. American Anesthesitist Grade (ASA) grade I-II; 3. Body mass index (BMI) 18-30kg/m^2; 4. Vital signs: respiratory frequency >= 10 and = 95%; systolic blood pressure (SBP) >= 90 mmHg and = 60 mmHg and = 55 and <= 100 times/min; 5. Understand the study process and methods, and voluntarily participate in this study.

Exclusion criteria

Exclusion criteria: 1. Associated with a contraindication to venous general anesthesia or has a previous history of unexpected anesthesia; 2. Known or suspected to be allergic or contraindication to propofol injections, cipofol injection excipients; 3. Combined with cerebral brain loss, intracranial hypertension, stroke, unstable angina pectoris, and myocardial infarction; 4. Respiratory insufficiency, obstructive pulmonary disease, presence of difficult airway or judged tracheal intubation difficulty (modified Marsh score grade III or IV); 5. Uncontrolled diabetes mellitus or hypertension; 6. Has severe liver dysfunction or severe renal insufficiency; 7. History of alcoholism or drug dependence; 8. Abuse or long-term application of anesthesia, sedation, and analgesic drugs; 9. With a previous history of mental illness; 10. Those who had participated in any drug clinical trial within 1 month prior to the screening; 11. The investigator considered any other subjects unsuitable to participate in this trial.

Design outcomes

Primary

MeasureTime frame
Success rate of anesthesia induction;

Countries

China

Contacts

Public ContactQi Qingling

The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine

qiqinglingdr@163.com+86 13512885015

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026